Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kelfred HoldingsHKSE:01134 +2.98%45 Days Payable is 64.82 as of Dec. 2025, which is 5% above its 10-year median of 61.57. GuruFocus rates HKSE:01134 with a GF Score™ of 45/100 and a GF Value™ of HK$0.44 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 793 Medical Devices & Instruments companies, Kelfred Holdings ranks better than 50.69% on this metric.
The historical rank and industry rank for Kelfred Holdings's Days Payable or its related term are showing as below:
HKSE:01134'
s Days Payable Range Over the Past 10 Years
Min: 43.42 Med: 61.57 Max: 78.63
Current: 70.17
During the past 10 years, Kelfred Holdings's highest Days Payable was 78.63. The lowest was 43.42. And the median was 61.57.
HKSE:01134's Days Payable is ranked better than 50.69% of 793
companies
in the Medical Devices & Instruments industry
Industry Median: 68.47
vs HKSE:01134: 70.17
Kelfred Holdings's Days Payable
increased
from Dec. 2024 (59.41) to Dec. 2025 (64.82).
It may suggest that Kelfred Holdingsdelayed paying its suppliers.
The historical data trend for Kelfred Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01134 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Kelfred Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kelfred Holdings Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kelfred Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Kelfred Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Kelfred Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kelfred Holdings (HKSE:01134) has a Days Payable of 64.82 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kelfred Holdings and its competitors. This is near median its historical median of 61.57. Over the past decade, Kelfred Holdings' Days Payable has ranged from 43.42 to 78.63. According to the industry distribution chart, Kelfred Holdings ranks #391 out of 793 companies in the Medical Devices & Instruments industry, placing it in the top 49.3%.
Is Kelfred Holdings' Days Payable too high?
Kelfred Holdings' current Days Payable of 64.82 is near median its 10-year median of 61.57. Over the past 10 years, this metric has ranged from a low of 43.42 to a high of 78.63. The Medical Devices & Instruments industry median Days Payable is 68.47. Kelfred Holdings' value of 64.82 is 5.3% below this industry median. Based on the distribution chart, Kelfred Holdings ranks #391 out of 793 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Kelfred Holdings has a GF Score™ of 45/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kelfred Holdings' Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Kelfred Holdings ranks #391 out of 793 companies for Days Payable. This puts Kelfred Holdings in the upper half of its industry. The industry median Days Payable is 68.47. Kelfred Holdings' value of 64.82 is 5.3% below this benchmark. Historically, Kelfred Holdings' own Days Payable has ranged from 43.42 to 78.63 over the past decade. While the company's 10-year median is 61.57 vs. the industry median of 68.47, Kelfred Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.47, based on 793 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kelfred Holdings's current Days Payable of 64.82 is 5.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kelfred Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kelfred Holdings's current Days Payable is 64.82, which is near median its own 10-year median of 61.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kelfred Holdings stock overvalued right now?
Based on GuruFocus' analysis, Kelfred Holdings (HKSE:01134) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$0.44, compared to a current price of HK$0.24 — trading 45% below its estimated fair value. The current Days Payable is 64.82, which is near median its 10-year median of 61.57 and 5.3% below the Medical Devices & Instruments industry median of 68.47. Kelfred Holdings' overall GF Score™ is 45/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Kelfred Holdings (HKSE:01134), the current Days Payable is 64.82 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kelfred Holdings (HKSE:01134) Overvalued in 2026?
Based on GuruFocus' analysis, Kelfred Holdings stock appears to be undervalued.
The current stock price of HK$0.24 is trading 45% below its estimated GF Value™ of HK$0.44.
GuruFocus considers Kelfred Holdings to be Significantly Undervalued.
Key valuation signals for HKSE:01134:
Days Payable: 64.82 (near median its 10-year median of 61.57)
GF Value™: HK$0.44 vs. price of HK$0.24 (45% below fair value)
Industry Position: 5.3% below the Medical Devices & Instruments median (#391 of 793)
No single metric tells the full story. See the HKSE:01134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kelfred Holdings Ltd is an investment holding company. The Company and its subsidiaries are principally engaged in the manufacturing and sales of eyewear products. It produces and sells a wide range of spectacle frames and sunglasses mainly through original design manufacturing (ODM) and original equipment manufacturing (OEM) business models. The group offers integrated and customised services, including product design and development, raw materials procurement, production, quality control, packaging, and delivery. The Group also offers (OBM) products under the brand name Miga. It operates in Italy, the United Kingdom, Hong Kong, the U.S., PRC, India, Spain, the Philippines, Japan, Australia, France, and other countries. It generates a majority of its revenue from the United Kingdom.
45GF Score
Get the complete analysis for HKSE:01134
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01134 has been successfully added to your 
